MOTS-c is real biology : It is encoded within mitochondrial DNA and has been shown in laboratory studies to influence metabolic pathways such as AMPK signaling, which is involved in energy balance and insulin sensitivity
Standard / Gradual Approach The escalation used in REDEFINE mirrors the standard semaglutide ladder, applied to both peptides at once: start at 0.25 mg of each per week and roughly double the step every four weeks toward a 2.4 mg + 2.4 mg weekly target [1]
Small molecules: Nrf2 activators, CoQ10, and NAD+ in cellular redox
UK readers should see our peptide legality article for the local picture
While research is still ongoing, here are some of the primary benefits reported from both animal studies and early human trials: 1
Survodutides identity is dual GLP-1/glucagon agonism without GIP, giving it a comparatively liver-focused design